Tumor incidence in Roquinsan/+ mice
| Age, mo . | Male, no. (%) . | Female, no. (%) . | Total, no. (%) . |
|---|---|---|---|
| 4-5 | ND | 4/11 (36) | 4/11 (36) |
| 6 | 14/36 (39) | 12/19 (63) | 26/55 (47) |
| 7 | 9/20 (45) | 29/38 (76) | 38/58 (66) |
| 8-15 | 15/36 (42) | 17/28 (61) | 32/64 (50) |
| Total | 38/92 (41) | 62/96 (65) | 100/188 (53) |
| Age, mo . | Male, no. (%) . | Female, no. (%) . | Total, no. (%) . |
|---|---|---|---|
| 4-5 | ND | 4/11 (36) | 4/11 (36) |
| 6 | 14/36 (39) | 12/19 (63) | 26/55 (47) |
| 7 | 9/20 (45) | 29/38 (76) | 38/58 (66) |
| 8-15 | 15/36 (42) | 17/28 (61) | 32/64 (50) |
| Total | 38/92 (41) | 62/96 (65) | 100/188 (53) |
Female sex bias: χ2 = .001.
ND indicates not determined.